Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Option Care Health, Inc. filings document the public-company disclosures of a Nasdaq-listed provider of home and alternate-site infusion services. Its common stock is registered under the symbol OPCH, and its regulatory record includes Current Reports on Form 8-K, proxy materials, and exhibits tied to operating results and corporate actions.
OPCH filings cover quarterly and annual financial results, non-GAAP measure reconciliations, Regulation FD investor presentations, amendments to its first lien credit agreement, executive officer changes and related severance matters, and definitive proxy disclosures. The proxy record addresses board governance, stockholder voting matters, executive compensation, and capital allocation context for the company's infusion services business.
Option Care Health Inc ownership disclosure: Vanguard Portfolio Management reported beneficial ownership of 8,201,422 shares of Common Stock, representing 5.24% of the class as of 03/31/2026. The filing notes these shares are held on behalf of Vanguard funds and managed accounts.
Option Care Health Chief Medical Officer Femi Adewunmi reported a tax-withholding disposition of 1,396 shares of Common Stock on April 22, 2026 at $28.38 per share. After this automatic withholding to cover tax obligations, Adewunmi directly holds 25,314 shares of Option Care Health Common Stock.
Option Care Health is asking stockholders at its 2026 virtual annual meeting to elect nine directors, ratify KPMG as independent auditor for 2026, and approve executive compensation on an advisory basis.
For 2025, the company reports net revenue of $5,649.5 million, up 13.0%, net income of $207.6 million, adjusted EBITDA of $471.3 million (up 6.2%), and adjusted EPS of $1.72 (up 8.9%). Cash provided by operating activities was $258.4 million. Management notes more than 2.5 million infusion events for over 315,000 patients, supported by about 8,000 team members.
The proxy emphasizes governance features such as one-share/one-vote, an independent board chair, annual director elections, proxy access, and stockholder-called special meetings at 25% ownership. Executive pay is heavily performance-based, with more than 85% of target CEO compensation tied to financial and stock performance, using annual incentives and PSU/RSU grants under robust ownership and clawback policies.
Option Care Health, Inc. entered into a Fifth Amendment to its Amended and Restated First Lien Credit Agreement with Bank of America, N.A. as administrative agent. The amendment adds new revolving credit commitments totaling $450,000,000, structured as an increase to the existing Revolving Credit Commitments.
Following this change, the aggregate principal amount of Revolving Credit Commitments available under the credit agreement is $850,000,000. This amendment updates the company’s senior secured lending facility and represents additional committed borrowing capacity rather than an immediate borrowing.
Option Care Health Inc — The Vanguard Group filed Amendment No. 4 to a Schedule 13G/A reporting 0 shares beneficially owned (representing 0% of the class) following an internal realignment. The filing cites SEC Release No. 34-39538 and states certain subsidiaries will report separately. The filing is signed by Ashley Grim on 03/27/2026.
Option Care Health director Pate R. Carter reported an open-market sale of company stock. On February 27, 2026, Carter sold 30,287 shares of Option Care Health common stock at a weighted average price of $32.0474 per share in multiple trades, leaving 11,623 shares held directly.
Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported an open-market sale of 6,000 shares of common stock at $33.00 per share. After this transaction, he directly owns 33,249 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Operating Officer Luke Whitworth reported a tax-related share disposition. On this Form 4, he transferred 4,605 shares of common stock at $33.815 per share to cover tax withholding, rather than executing an open-market sale. After this transaction, he directly holds 169,589 common shares.